Neonatal Hyperbilirubinemia and Bilirubin Neurotoxicity: What Can Be Learned from the Database Analysis?
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Zhang Y, Li S, Li L, Huang H, Fu Z, Hua Z J Neuroimmune Pharmacol. 2024; 19(1):23.
PMID: 38775885 DOI: 10.1007/s11481-024-10124-y.
Zhang Y, Li S, Li L, Huang H, Fu Z, Hua Z In Vitro Cell Dev Biol Anim. 2024; 60(2):161-171.
PMID: 38216855 DOI: 10.1007/s11626-023-00844-5.
Babaie E, Hassanpour K, Aldaghi M, Sahebkar M J Res Med Sci. 2023; 28:40.
PMID: 37213445 PMC: 10199377. DOI: 10.4103/jrms.jrms_894_21.
References
1.
Qattea I, Farghaly M, Elgendy M, Mohamed M, Aly H
. Neonatal hyperbilirubinemia and bilirubin neurotoxicity in hospitalized neonates: analysis of the US Database. Pediatr Res. 2021; 91(7):1662-1668.
DOI: 10.1038/s41390-021-01692-3.
View
2.
Brooks J, Fisher-Owens S, Wu Y, Strauss D, Newman T
. Evidence suggests there was not a "resurgence" of kernicterus in the 1990s. Pediatrics. 2011; 127(4):672-9.
DOI: 10.1542/peds.2010-2476.
View
3.
Hansen T, Nietsch L, Norman E, Bjerre J, Hascoet J, Mreihil K
. Reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr. 2009; 98(10):1689-94.
DOI: 10.1111/j.1651-2227.2009.01409.x.
View
4.
Harris M, Bernbaum J, Polin J, Zimmerman R, Polin R
. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics. 2001; 107(5):1075-80.
DOI: 10.1542/peds.107.5.1075.
View
5.
Okolie F, South-Paul J, Watchko J
. Combating the Hidden Health Disparity of Kernicterus in Black Infants: A Review. JAMA Pediatr. 2020; 174(12):1199-1205.
DOI: 10.1001/jamapediatrics.2020.1767.
View